Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Denton

Showing results (151-160 of 484) with videos related to

Pageof 49
Sort By:
Clinical and Experimental Rheumatology|February 22, 2018
Autologous fat transfer in the successful treatment of upper limb linear morphoeaSebastiano Mura, Alessandra Fin, Pier Camillo Parodi, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis Research & Therapy|April 20, 2010
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of sclerodermaEmma C Derrett-Smith, Audrey Dooley, Korsa Khan, et al.
Arthritis and Rheumatism|August 29, 2009
Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosisMohit Kapoor, Matthew McCann, Shangxi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2019
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO RegistryLoïc Guillevin, Elke Hunsche, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Nature Reviews. Rheumatology|February 27, 2023
State-of-the-art evidence in the treatment of systemic sclerosisJanet E Pope, Christopher P Denton, Sindhu R Johnson, et al.
Annals of the Rheumatic Diseases|November 28, 2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO RegistryMarco Matucci-Cerinic, Thomas Krieg, Loic Guillevin, et al.
Stem Cell Research & Therapy|February 9, 2017
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicineMichelle Griffin, Caroline M Ryan, Omar Pathan, et al.
Pageof 49

Showing results (151-160 of 484) with videos related to

Sort By:
Pageof 49
Clinical and Experimental Rheumatology|February 22, 2018
Autologous fat transfer in the successful treatment of upper limb linear morphoeaSebastiano Mura, Alessandra Fin, Pier Camillo Parodi, et al.
Rheumatology (Oxford, England)|June 13, 2018
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung diseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Arthritis Research & Therapy|April 20, 2010
Systemic vasculopathy with altered vasoreactivity in a transgenic mouse model of sclerodermaEmma C Derrett-Smith, Audrey Dooley, Korsa Khan, et al.
Arthritis and Rheumatism|August 29, 2009
Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosisMohit Kapoor, Matthew McCann, Shangxi Liu, et al.
American Journal of Respiratory and Critical Care Medicine|December 17, 2019
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung DiseaseDinesh Khanna, Donald P Tashkin, Christopher P Denton, et al.
Clinical and Experimental Rheumatology|August 6, 2013
Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO RegistryLoïc Guillevin, Elke Hunsche, Christopher P Denton, et al.
Journal of Scleroderma and Related Disorders|July 5, 2021
Clinical trial protocol: PRednisolone in early diffuse cutaneous Systemic Sclerosis (PRedSS)Ariane L Herrick, Deborah J Griffiths-Jones, W David Ryder, et al.
Nature Reviews. Rheumatology|February 27, 2023
State-of-the-art evidence in the treatment of systemic sclerosisJanet E Pope, Christopher P Denton, Sindhu R Johnson, et al.
Annals of the Rheumatic Diseases|November 28, 2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO RegistryMarco Matucci-Cerinic, Thomas Krieg, Loic Guillevin, et al.
Stem Cell Research & Therapy|February 9, 2017
Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicineMichelle Griffin, Caroline M Ryan, Omar Pathan, et al.
Pageof 49